Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack

Stroke

Volumn 33, Issue 6, 2002, Pages 1677-1684

  Alkayed, Nabil J ^a   Goyagi, Toru ^a   Joh, Hung Dong ^a   Klaus, Judith ^a   Harder, David R ^b   Traystman, Richard J ^a   Hurn, Patricia D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cerebral ischemia, transient; Gene expression; Neuroprotection; Rats; Stroke, experimental

Indexed keywords

CYTOCHROME P450 2C11; EPOXYICOSATRIENOIC ACID; IODOPHENAZONE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INDUCTION; ENZYME REGULATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; STROKE; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; AUTORADIOGRAPHY; BLOOD FLOW VELOCITY; BLOTTING, WESTERN; BRAIN; CEREBROVASCULAR CIRCULATION; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; ENZYME INDUCTION; FEMALE; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; ISCHEMIC PRECONDITIONING; LIVER; MALE; RATS; RATS, WISTAR; REPERFUSION; RNA, MESSENGER; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES; UP-REGULATION;

EID: 0036277938     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000016332.37292.59     Document Type: Article

References (63)

1. Attenuated stroke severity after prodromal TIA: A role for ischemic tolerance in the brain?
2. Do transient ischemic attacks have a neuroprotective effect?
3. Could transient ischemic attacks have a cerebroprotective role?
4. Ischemic tolerance in the brain
5. Invited response to: Hakim AM. Could transient ischemic attacks have a cerebroprotective role?
6. Ischemic preconditioning and tolerance in human brain
7. Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice
8. Stress proteins and tolerance to focal cerebral ischemia
9. Induction of ischemic tolerance and antioxidant activity by brief focal ischemia
10. Ischemic tolerance and lipid peroxidation in the brain
11. Ischemic preconditioning and brain tolerance: Temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression
12. Brain tissue responses to ischemia
13. The late phase of preconditioning
14. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes
15. Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats
16. Functional hyperemia in the brain: Hypothesis for astrocyte-derived vasodilator metabolites
17. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid
18. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone
19. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow
20. Determination of cytochrome p450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs
21. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes
22. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone
23. Gender-linked brain injury in experimental stroke
24. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats
25. Social stress exacerbates stroke outcome by suppressing Bcl-2 expression
26. Estrogen and Bcl-2: Gene induction and effect of transgene in experimental stroke
27. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: Comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6
28. Cerebral microvascular endothelial cell tube formation: Role of astrocytic epoxyeicosatrienoic acid release
29. Transient forebrain ischemia protects against subsequent focal cerebral ischemia without changing cerebral perfusion
30. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells
31. Anti-inflammatory properties of cytochrome P450 epoxygenasederived eicosanoids
32. Role of cytochrome P-450 in endogenous antipyresis
33. Calcium influx factor: Further evidence it is 5,6-epoxyeicosatrienoic acid
34. 14,15-Epoxyeicosatrienoic acid inhibits platelet aggregation in mouse cerebral arterioles
35. 16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke
36. bcl-2 antisense treatment prevents induction of tolerance to focal ischemia in the rat brain
37. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons
38. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice
39. Calcium movement in ischemia-tolerant hippocampal CA1 neurons after transient forebrain ischemia in gerbils
40. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide
41. Respiratory chain inhibition induces tolerance to focal cerebral ischemia
42. Ischemic tolerance in murine cortical cell culture: Critical role for NMDA receptors
43. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning
44. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning
45. Opening of ATP-sensitive potassium channels by cromakalim confers tolerance against chemical ischemia in rat neuronal cultures
46. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning
47. An essential role of the JAK-STAT pathway in ischemic preconditioning
48. Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids
49. Overexpression of C-terminal Src kinase blocks 14, 15-epoxyeicosatrienoic acid-induced tyrosine phosphorylation and mitogenesis
50. Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor
51. Bimodal regulation of ceramidase by interleukin-1beta: Implications for the regulation of cytochrome p450 2C11
52. + channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes
53. Preconditioning does not prevent postischemic dysfunction in aging heart
54. No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits
55. Ischemic preconditioning in 18- to 20-month-old gerbils: Long-term survival with functional outcome measures
56. Protection conferred by preinfarct angina is manifest in the aged heart: Evidence from the TIMI 4 trial
57. Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction
58. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction
59. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction
60. Regulation of hepatic cytochrome P450 2C11 via cAMP: Implications for down-regulation in diabetes, fasting, and inflammation
61. Cytochrome P450 2C is an EDHF synthase in coronary arteries
62. Functional role of epoxyeicosatrienoic acids and their production in astrocytes: Approaches for gene transfer and therapy
63. Epoxide hydrolases: Biochemistry and molecular biology